NuttDJ. The psychobiology of posttraumatic stress disorder. J Clin Psychiatry2000; 61 (Suppl 5):24–9.
2.
KeckPEMcElroySLFriedmanLM. Valproate and carbamezapine in the treatment of panic and posttraumatic stress disorder, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol1992;12 (Suppl):36S–41S.
3.
LipperSDavidsonJRTGradyTAEdingerJDHammettERMahorneySI, and others. Preliminary study of carbamezapine in post-traumatic stress disorder. Psychosomatics1986;27:849–54.
4.
WolfMEAlvaiAMosnaimAD. Posttraumatic stress disorder in Vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamezapine. Biol Psychiatry1988;23:642–4.
5.
StewartJTBartucciRJ. Posttraumatic stress disorder and partial complex seizures. Am J Psychiatry1986;143:113–4.
6.
GrantSMFauldsD.Oxcarbezapine: A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs1992;43:873–88.
7.
HamiltonM.The assessment of anxiety states by rating. Br J Med Psychol1959;32:50–5.
8.
National Institute of Mental Health. CGI: Clinical Global Impression. In: GuyWBonatoRR, editors. Manual for the ECDEU Assessment Battery. Revised 2nd ed.Chevy Chase (MD): National Institute of Mental Health; 1970. 12.1–12.6.
9.
McAuleyJWBiedermanTSSmithJCMooreJL. Newer therapies in the drug treatment of epilepsy. Ann Pharmacother2002;36:119–28.
10.
FisherRS. Epilepsy. In: EnnaSJCoyleJT, editors. Pharmacologic management of neurological and psychiatric disorders.New York: McGraw Hill; 1998. p 459–503.
11.
BarcsGWalkerEBElgerCEScarmelliAStefanHSturmY, and others. Oxcarbazepine placebo-controlled dose ranging trial in refractory partial epilepsy. Epilepsia2000;41:1597–607.
12.
Novartis. Trileptal package insert. East Hanover (NJ): Novartis; 2001.